477
Participants
Start Date
April 22, 2024
Primary Completion Date
November 30, 2025
Study Completion Date
December 31, 2025
Pimecrolimus 0.3% Ophthalmic Ointment
Pimecrolimus 0.3% Ophthalmic Ointment will be applied twice a day to both eyelid margins.
Placebo Ophthalmic Ointment
Placebo will be applied twice a day to both eyelid margins.
Clinical Investigator Site, Cranberry Township
Clinical Investigator Site, Havre de Grace
Clinical Investigator Site, Lynchburg
Clinical Investigator Site, Garner
Clinical Investigator Site, Morrow
Clinical Investigator Site, Atlanta
Clinical Investigator Site, Tampa
Clinical Investigator Site, Largo
Clinical Investigator Site, Crystal River
Clinical Investigator Site, Smyrna
Clinical Investigator Site, Louisville
Clinical Investigator Site, Cincinnati
Clinical Investigator Site, Medina
Clinical Investigator Site, Washington
Investigative Site, St Louis
Clinical Investigator Site, Kansas City
Clinical Investigator Site, Pittsburg
Clinical Investigator Site, San Antonio
Clinical Investigator Site, Austin
Clinical Investigator Site, Lakeway
Clinical Investigator Site, Aurora
Clinical Investigator Site, Clinton
Clinical Investigative Site, Phoenix
Clinical Investigator Site, Inglewood
Clinical Investigator Site, Glendale
Clinical Investigator Site, Newport Beach
Clinical Investigator Site, Garden Grove
Clinical Investigator Site, Petaluma
Clinical Investigator Site, Rancho Cordova
Famy Life Sciences, a Viatris Company
INDUSTRY